ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2291

Enhanced Release of S100A9 and Hepatocyte Growth Factor by the Epidermis in Systemic Sclerosis

Joanna Nikitorowicz Buniak1, Christopher P. Denton1, David J. Abraham2 and Richard J. Stratton1, 1Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, London, United Kingdom, 2UCL Medical School, London, United Kingdom

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Calgranulin, chemokines, cytokines, growth factors and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud’s – Pathogenesis, Animal Models and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Systemic sclerosis (SSc) is a severe disease of unknown aetiology characterised by cellular injury and activation in early stage, followed by autoimmunity and fibrosis. Much of the work is focused on the fibroblasts however, keratinocytes are known to be able to secrete chemo-attracting agents, as well as growth factors influencing phenotype and proliferation rate of fibroblasts. We have recently shown that SSc epithelial cells exhibit an activated phenotype similar to wound healing. Data from hypertrophic scaring and keloids demonstrate that epidermis can promote dermal fibrosis. Therefore, we decided to look for evidence that in SSc injured epidermal cells are releasing chemokines and cytokines capable of recruiting immune cells to the skin and promoting fibrosis. 

Methods:

Forearm biopsies were taken from 12 healthy controls and 12 SSc patients. Dermis and epidermis were separated using trypsin/EDTA and the explants incubated overnight in serum free media. The conditioned media were then collected and analysed using Legend PLEX (BioLegend) for presence of G-CSF, GM-CSF, VEGF, PDGF-AA, PDGF-BB, MCP-1, FGF-2, IL-8, IL-6, IL-1α, IL-1β, and IL-1ra. Additionally, HGF, CCL20 and S100A9 were measure by ELISA (R&D Systems). Moreover, immunohistochemistry was performed on skin biopsies of 6 dcSSc and 6 healthy controls using antibodies against S100A9, S100A8, loricrin and involucrin. The epidermal thickness and cell area were also measured.  The statistical analysis was performed using Wilcoxon rank-sum test. 

Results:

The conditioned media analysis revealed significantly higher levels of HGF (p<0.005) and S100A9 (p< 0.05) released by SSc epidermis. Also increased levels of FGF-2, VEGF-A and PDGF-AA and IL-8 found in the SSc epidermis conditioned media showed a trend towards significance. Staining of skin sections confirmed much higher levels of S100A9 in SSc present throughout the epidermis, compared to positive staining in the healthy skin only around epidermal appendages. The SSc epidermis showed significant increase in thickness (p<0.05) and hypertrophic cells in basal (p<0.005) and spinous layers (p<0.005). The expression of involucrin and loricrin was also altered.

Conclusion:

The epidermis provides a potential source of chemokines in SSc. High levels of pro-inflammatory S100A9 released by SSc dermis might contribute to the inflammation and therefore skin fibrosis. The abnormal thickness, hypertrophic keratinocytes and altered expression of differentiation markers in SSc epidermis suggest changes in terminal differentiation and signalling. The increase in HGF release by SSc epidermis is consistent with our previous report of enhanced c-Met activation in SSc epidermis and, indicates autocrine stimulation that could be responsible for the changes observed. However, more investigations are required to fully explore the mechanisms underlying S100A9 and c-Met/HGF signaling and they role of in skin fibrosis.


Disclosure:

J. Nikitorowicz Buniak,
None;

C. P. Denton,
None;

D. J. Abraham,
None;

R. J. Stratton,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/enhanced-release-of-s100a9-and-hepatocyte-growth-factor-by-the-epidermis-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology